People | January 04, 2026
Aarti Pharmalabs appoints Dr. Rakeshwar Bandichhor as Chief Scientific Officer
Dr. Bandichhor brings nearly two decades of experience from Dr. Reddy's Laboratories
Dr. Bandichhor brings nearly two decades of experience from Dr. Reddy's Laboratories
Singh previously served as Head of IT (Development and Manufacturing Services) at Syngene International Limited, Lead of IT Manufacturing at UPL, and AGM at The Hi-Tech Gears
The portfolio, purchased from a leading multinational generic manufacturer, addresses a market valued at $473.2 million for the 12 months ending August 2025
The acquisition adds HLD-0915, a once-daily oral therapy for prostate cancer, to Johnson & Johnson’s nearly 20-year legacy of innovation in the disease
The resubmission of BLA for MOLBREEVI names Fujifilm as the drug substance manufacturer
It performs white blood cell differential counts and quantifies red blood cell and platelet morphology,
Applications include detailed scientific rationale and supporting clinical evidence
The applications aim to launch Phase Ib/II trials for relapsed/refractory multiple myeloma and primary plasma cell leukemia, respectively
Astal estimates the collaboration will generate incremental revenue of approximately Rs. 300 crore upon implementation
INOVIO remains confident in the therapy’s benefits and intends to meet with the FDA to discuss maintaining eligibility under this pathway
Subscribe To Our Newsletter & Stay Updated
